Congress trades

Haemonetics Corporation (HAE)

NYSE · Healthcare · 13 congress trades · last filed 5 years ago

13
Congress disclosures shown
17d
Median delay on the congress disclosures
of the 45 day limit
6/7
Purchases and sales in the disclosures shown

About Haemonetics Corporation

from the company's filings and listing
Exchange
NYSE
Sector
Healthcare
Industry
Medical - Devices
Chief executive
Christopher A. Simon
Employees
3,009
Listed since
May 10, 1991
Market value
$4.7B
Price to earnings
50.1
Earnings per share
$2.12
Dividend yield
-

www.haemonetics.com

Earnings

6 reported quarters · next on Nov 5, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q1 FY2027reported Aug 6, 2026$1.14$1.08$339.4M$327.9MEPS beatRevenue beat
May 7, 2026$1.29$1.28$346.4M$336.8MEPS in lineRevenue beat
Q3 FY2026reported Feb 5, 2026$1.31$1.27$339.0M$331.9MEPS beatRevenue beat
Q2 FY2026reported Nov 6, 2025$1.27$1.12$327.3M$329.8MEPS beatRevenue in line
Q1 FY2026reported Aug 7, 2025$1.10$1.01$321.4M$320.0MEPS beatRevenue in line
May 8, 2025$1.24$1.22$330.6M$312.5MEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2026 · proxy filed Jun 9, 2026
ExecutiveSalaryStock awardsOtherTotal
Christopher A. SimonPresident and Chief Executive Officer$1.1M$7.6M$3.4M$12.0M
James C. D'AreccaExecutive Vice President, Chief Financial Officer$604K$1.8M$1.2M$3.6M
Michelle L. BasilExecutive Vice President, General Counsel$559K$1.7M$1.1M$3.4M
Frank W. ChanExecutive Vice President, Chief Operating Officer$518K$1.5M$1.3M$3.3M
Roy GalvinExecutive Vice President, Chief Commercial Officer$550K$1.5M$1.0M$3.0M

The summary compensation table from the 2026 proxy statement, current executives only. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$443.2M5,909,258+5.1%13.03%
Neuberger Berman Group LLC$313.5M4,179,443+17.4%9.21%
Vanguard Portfolio Management LLC$191.0M2,546,394-0.5%5.61%
AQR Capital Management LLC$165.0M2,266,489-32.5%5.00%
Ariel Investments, LLC$154.6M2,060,966+100.0%4.54%
Vanguard Capital Management LLC$154.5M2,059,578-1.5%4.54%
State Street Corp$136.4M1,818,186+2.6%4.01%
Dimensional Fund Advisors LP$118.9M1,585,222+19.5%3.49%
Citadel Advisors LLC$113.3M1,510,120+485.0%3.33%
Geode Capital Management, LLC$96.6M1,287,240+5.6%2.84%
River Road Asset Management, LLC$96.4M1,285,602-3.2%2.83%
Arrowstreet Capital, Limited Partnership$86.7M1,155,351-16.5%2.55%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next HAE filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in HAE

13 disclosures of 13 on record · median 17d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Lois FrankelStockSale$1,001 - $15,000+67.9%S&P +81.9% · vs S&P 500 -14.0%May 6, 2021May 25, 202119d
Lois FrankelStockSale$1,001 - $15,000+69.0%S&P +80.6% · vs S&P 500 -11.6%May 7, 2021May 25, 202118d
Josh GottheimerJointStockSale$1,001 - $15,000-16.2%S&P +98.4% · vs S&P 500 -114.6%Jan 25, 2021Feb 9, 202115d
Josh GottheimerJointStockPurchase$1,001 - $15,000+10.0%S&P +119.7% · vs S&P 500 -109.7%Oct 16, 2020Nov 5, 202020d
Josh GottheimerJointStockSale$1,001 - $15,000+19.6%S&P +124.2% · vs S&P 500 -104.6%Sep 15, 2020Oct 13, 202028d
Lois FrankelStockPurchase$1,001 - $15,000+22.2%S&P +126.5% · vs S&P 500 -104.3%Aug 14, 2020Aug 24, 202010d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000-6.1%S&P +149.5% · vs S&P 500 -155.6%Jun 1, 2020Jun 16, 202015d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+1.9%S&P +161.0% · vs S&P 500 -159.1%May 19, 2020Jun 16, 202028d
Josh GottheimerJointStockPurchase$1,001 - $15,000-6.7%S&P +151.7% · vs S&P 500 -158.4%May 28, 2020Jun 10, 202013d
Josh GottheimerJointStockPurchase$1,001 - $15,000+2.8%S&P +166.5% · vs S&P 500 -163.7%May 15, 2020Jun 10, 202026d
Lois FrankelStockSale$1,001 - $15,000-2.2%S&P +167.1% · vs S&P 500 -169.4%Aug 7, 2018Aug 24, 201817d
Lois FrankelStockSale$1,001 - $15,000+7.7%S&P +173.7% · vs S&P 500 -166.0%Jun 14, 2018Jun 22, 20188d
Lois FrankelStockSale$1,001 - $15,000+11.2%S&P +175.1% · vs S&P 500 -163.9%Jun 7, 2018Jun 22, 201815d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Questions

Which members of Congress have traded HAE?

Lois Frankel, Josh Gottheimer, Gilbert Ray Cisneros, Jr. disclosed HAE transactions in the filings shown here.

How quickly are HAE trades disclosed?

Congressional disclosures took a median of 17 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days late, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track